SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Matin TJ, Suda T 1988 Osteoblastic cells are involved in osteoclast formation. Endocrinology 123:26002602.
  • 2
    Akatsu T, Tamura T, Takahashi N, Udagawa N, Tanaka S, Sasaki T, Yamaguchi A, Nagata N, Suda T 1992 Preparation and characterization of a mouse osteoclast-like multinuclearted cell population. J Bone Miner Res 7:12971306.
  • 3
    Suda T, Takahashi N, Matin TJ 1992 Modulation of osteoclast differentiation. Endocr Rev 13:6680.
  • 4
    Roodman GD 1995 Osteoclast function in Paget's disease and multiple myeloma. Bone 17:57S.
  • 5
    Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, Sato K, Shimizu M, Maini R, Feldmann M, Kishimoto T 1988 Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18:17971801.
  • 6
    Horowitz MC 1993 Cytokines and estrogen in bone: anti-osteoporotic effects. Science 260:626627.
  • 7
    Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345357.
  • 8
    Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 95:35973602.
  • 9
    Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165176.
  • 10
    Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315323.
  • 11
    Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Amgen EST Program, Boyle WJ 1997 Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309319.
  • 12
    Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T, Higashio K 1997 Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 234:137142.
  • 13
    Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR 1990 Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248:12301234.
  • 14
    Vieira P, de Waal-Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, de Vries JE, Roncarolo MG, Mosmann TR, Moore KW 1991 Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci U S A 88:11721176.
  • 15
    De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE 1991 Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:12091220.
  • 16
    MacNeil IA, Suda T, Moore KW, Mosmann TR, Zlotnik A 1990 IL-10, a novel growth cofactor for mature and immature T cells. J Immunol 145:41674173.
  • 17
    Chen WF, Zlotnik A 1991 IL-10: A novel cytotoxic T cell differentiation factor. J Immunol 147:528534.
  • 18
    Thompson-Snipes L, Dhar V, Bond MW, Mosmann TR, Moore KW, Rennick DM 1991 Interleukin 10: A novel stimulatory factor for mast cells and their progenitors. J Exp Med 173:507510.
  • 19
    Owens JM, Gallagher AC, Chambers TJ 1996 IL-10 modulates formation of osteoclasts in murine hemopoietic cultures. J Immunol 157:936940.
  • 20
    Xu LX, Kukita T, Kukita A, Otsuka T, Niho Y, Iijima T 1995 Interleukin-10 selectively inhibits osteoclastogenesis by inhibiting differentiation of osteoclast progenitors into preosteoclast-like cells in rat bone marrow culture system. J Cell Physiol 165:624629.
  • 21
    Lamb P, Kessler LV, Suto C, Levy DE, Seidel HM, Stein RB, Rosen J 1994 Rapid activation of proteins that interact with the interferon gamma activation site in response to multiple cytokines. Blood 83:20632071.
  • 22
    Schindler C, Darnell JE Jr 1995 Transcriptional responses to polypeptide ligands: The JAK-STAT pathway. Annu Rev Biochem 64:621651.
  • 23
    Taniguchi T 1995 Cytokine singnaling through nonreceptor protein tyrosine kinases. Science 268:251255.
  • 24
    Bacon CM, Petricoin III EF, Ortaldo JR, Rees RC, Larner AC, Johnston JA, O'Shea J 1995 Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci U S A 92:73077311.
  • 25
    Jacobson NG, Szabo SJ, Weber-Nordt RM, Zong Z, Schreiber RD, Darnell JE Jr, Murphy KM 1995 Interleukin 12 signaling in T helper type 1 cells involves tyrosine phosphorylation of signal transducer and activator of transcription (stat)3 and stat4. J Exp Med 181:17551762.
  • 26
    Finbloom DS, Winestock KD 1995 IL-10 induces the tyrosine phosphorylation of tyk2 and jak1 and differential assembly of STAT1α and STAT3 complexes in human T cells and monocytes. J Immunol 155:10791090.
  • 27
    Larner AC, David M, Feldman GM, Igarashi KI, Hackett RH, Webb DSA, Sweitzer SM, Petricoin III EF, Finbloom DS 1993 Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. Science 261:17301733.
  • 28
    O'Farrell AM, Liu Y, Moore KW, Mui ALF 1998 IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: Evidence for Stat3-dependent and -independent pathways. EMBO J 17:10061018.
  • 29
    Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K, Taga T, Kishimoto T, Suda T 1993 Soluble interleukin-6 receptor trroggers osteoclast formation by interleukin 6. Proc Natl Acad Sci U S A 90:1192411928.
  • 30
    Udagawa N, Takahashi N, Katagiri T, Tamura T, Wada S, Findlay DM, Matin TJ, Hirota H, Taga T, Kishimoto T, Suda T 1995 Interleukin (IL)-6 induction of osteoclast differentiation dependents on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med 182:14611468.
  • 31
    Iotsova V, Caamano J, Loy J, Yang Y, Lewin A, Bravo R 1997 Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 3:12851289.
  • 32
    Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa S 1990 The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442444.
  • 33
    Yoshidome H, Kato A, Edwards MJ, Lentsch AB 1999 Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: Implications of a central role for nuclear factor kappaB. Hepatology 30:203208.
  • 34
    Nakashima K, Yanagisawa M, Arakawa H, Kimura N, Hisatsune T, Kawabata M, Miyazono K, Taga T 1999 Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science 284:479482.
  • 35
    Zhu M, John S, Berg M, Leonard WJ 1999 Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling. Cell 96:121130.
  • 36
    Horvai AE, Xu L, Korzus E, Brard G, Kalafus D, Mullen TM, Rose DW, Rosenfeld MG, Glass CK 1997 Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci U S A 94:10741079.
  • 37
    Webster GA, Perkins ND 1999 Transcriptional cross talk between NF-kappaB and p53. Mol Cell Biol 19:34853495.
  • 38
    Takahashi N, Mundy GR, Roodman GD 1986 Recombinant human interferon-inhibits formation of formation of human osteoclast-like cells. J Immunol 137:35443549.